Minimal residual disease (MRD) assessment by flow cytometry after ASCT for AL amyloidosis: are we there yet? Academic Article uri icon

Overview

publication date

  • March 13, 2017

Research

keywords

  • Flow Cytometry
  • Immunoglobulin Light-chain Amyloidosis
  • Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 85015027044

Digital Object Identifier (DOI)

  • 10.1038/bmt.2017.28

PubMed ID

  • 28287637

Additional Document Info

volume

  • 52

issue

  • 6